% Expired Patents = 25.0

Forward Citations = 56

Loading Chart...

3 inventors (with patents filed for the assignee):

David Aaron Schwartz (4 out of 47 patents)

Richard I Hogrefe (1 out of 18 patents)

Leopoldo Mendoza (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 8541555 - Hydrazone-based and oxime-based fluorescent and chromophoric/pro-fluorescent and pro-chromophoric reagents and linkers (2013-09-24),

2. 7999098 - Triphosphate oligonucleotide modification reagents and uses thereof (2011-08-16),

3. 7462689 - Hydrazine-based and carbonyl-based bifunctional crosslinking reagents (2008-12-09),

4. 6800728 - Hydrazine-based and carbonyl-based bifunctional crosslinking reagents (2004-10-05),

Company Overview

Solulink Biosciences, Inc. is a leading provider of antibody-drug conjugation solutions for the life science industry. The company's products enable researchers to easily and efficiently link antibodies to drugs or other molecules, enhancing the effectiveness of targeted therapies. Solulink's innovative technology has been widely adopted by pharmaceutical companies, academic research institutions, and diagnostic labs worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#1,006 in San Diego, CA

#14,041 in California

#60,597 in US

San Diego, CA, United States of America

Solulink Biosciences, Inc.

Forward Citations = 56

3 inventors:

David Aaron Schwartz (4 out of 47 patents)

Richard I Hogrefe (1 out of 18 patents)

Leopoldo Mendoza (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Solulink Biosciences, Inc.. Retrieved from https://idiyas.com/company/solulink-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]